Commentary

Nulla eu felis ligula. Nulla porttitor sapien auctor odio lobortis sagittis. Nulla facilisi. Etiam aliquet arcu ac tempor luctus. Nunc eleifend mi faucibus tellus maximus, sed auctor turpis faucibus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Integer quis velit vel erat maximus feugiat nec vitae lacus. Nulla facilisi.

Sed quis vestibulum mauris. Fusce varius cursus est, ac auctor lorem rutrum sit amet. Suspendisse vel lacus eget libero auctor aliquam at nec sapien. Donec auctor, neque in tincidunt mollis, quam leo sagittis nisl, a tempor velit nunc at dui. Morbi malesuada sit amet ligula vel euismod. Cras porttitor orci non justo imperdiet vulputate. Morbi in nibh pretium, finibus augue rhoncus, pulvinar lectus. Nunc sollicitudin tempor volutpat.

12 Jan

Posted at 09:12h in Portfolio Updates

TPS updates-  Working actively on research on new positions, updates on existing positions, and what new members can buy now Lots of new members, so here is advice for those recently joining below and updates on all positions for everyone. We have been on fire with...

04 Jan

Posted at 12:50h in Portfolio Updates

PRVB 17.60 It's up today in a down market on the FDA accepting the BLA for Teplizumab. That said, we are taking the gains of 70% on the final 1/2 after 18 months of holding this stock.  This could continue to work higher but we are...

29 Dec

Posted at 08:29h in Portfolio Updates

Dave Banister, Chief Strategist, Themarketanalysts.com The markets remain a bit extended but we also just had a nice 3 week consolidation in the SP 500 and could still work up to my 3996 Major 5 target over next several weeks. There are plenty of money supply...

23 Dec

Posted at 10:03h in Uncategorized

TBIO 22.88 Avg net entry around 15-15.50 Closing this out as Vaccine stocks are losing luster, this may do very well long term.  That said, we sold 1/3 for 75-80% gains at 27.50 a few weeks ago, now closing out to make room for new 1st quarter...

21 Dec

Posted at 10:07h in Portfolio Updates

Today I am doing some quick updates on our 9 portfolio names , I plan to have 3 more with 12 being the max. Each position should be about 8% of a TPS allocation portfolio. Obviously I weight this in smaller cap names and Biotech in...

TPS
Tipping Point Stocks

Contact us at
support@TippingPointStocks.com
with any questions. We respond
within 5-15 minutes usually.

This material should not be considered investment advice. The Market Analysts Group, LLC, TippingPointStocks.com, Stockreversalspremium.com , StockReversals.com and or any of our affiliates are not a registered investment advisor. Under no circumstances should any content from this website, articles, videos, seminars or emails from TippingPointStocks.com, Stockreversals.com or Stockreversalspremium.com or any of its affiliates be used or interpreted as a recommendation to buy or sell any type of security or commodity contract. This material is not a solicitation for a trading approach to financial markets. Any investment decisions must in all cases be made by the reader or by his or her registered investment advisor. This information is for educational purposes only. All communications are subject to our Terms of Use Agreement

Disclaimer: CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

All communications are subject to our terms of use agreement

indian xxnx horny desi indian cheating slime wife show boobs in webcam.